$IMGN
Immunogen, Inc.
PRICE
$3.98 ▲3.646%
Extented Hours
VOLUME
3,169,812
DAY RANGE
3.56 - 3.85
52 WEEK
3.36 - 7.77
Key Metrics
Market Cap
846.86 M
Beta
1.51
Avg. Volume
4.64 M
Shares Outstanding
220.54 M
Yield
0%
Public Float
0
Next Earnings Date
2022-07-29
Next Dividend Date
Company Information
ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, the company aims to disrupt the progression of cancer and offer its patients more good days.
CEO: Mark Enyedy
Website: www.immunogen.com
HQ: 84 State St Boston, 02109-2202 Massachusetts
Related News